{"database": "openregs", "table": "documents", "rows": [["FDA-2016-D-4308-0006", "FDA", "FDA-2016-D-4308", "Reference 3 Compliance Program Guidance Manual Chapter 42  Blood and Blood Components Inspection of Licensed and Unlicensed Blood Banks Brokers Reference Laboratories and Contractors 7342_001 dated Jun 1 16 re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry", "Supporting & Related Material", "Background Material", "2017-01-03T05:00:00Z", 2017, 1, null, null, "2017-01-03T15:13:44Z", null, 0, 0, "0900006482446f19"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2016-D-4308-0006"], "units": {}, "query_ms": 0.3913599066436291, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}